2seventy bio - Ownership and Business Overview

Life ScienceCompany

2seventy bio Ownership

Who owns 2seventy bio?

2seventy bio is owned by Bristol-Myers Squibb. It was acquired on March 10, 2025.

2seventy bio Business Overview

Where is 2seventy bio headquartered?

2seventy bio is headquartered in Cambridge, Massachusetts.

What is 2seventy bio’s revenue?

2seventy bio disclosed revenue of 100M USD for 2023 and 91M USD for 2022.

What sector is 2seventy bio in?

2seventy bio is a life science company.

When was 2seventy bio founded?

2seventy bio was founded in 2021.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Join Mergr to view all 55 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 52 by strategics.

2seventy bio

2seventy bio, Inc.

60 Binney St.,
Cambridge, Massachusetts 02142
United States,
(617) 675-7270
www.2seventybio.com

2seventy bio is an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. 2seventy bio was formed in 2021 and is based in Ottawa, Ontario.


 Subscribe to unlock this and 212,263
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 205K M&A Transactions
  • 208K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.